Your search returned 235 studies. (Get alerts for new studies):
- Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer - Venous Thromboembolism
1 Location available
- Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Conditions: Carcinoma, Giant Cell - Carcinoma, Non-Small-Cell Lung - Lung Cancer
1 Location available
- Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surge
Conditions: Lung Cancer
1 Location available
- Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm - Carcinoma Non-small Cell Lung Cancer Stage IIIA - Carcinoma Non-small Cell Lung Cancer Stage IIIB - Carcinoma Non-small Cell Lung Cancer Stage IV
50 Locations available
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
Conditions: Cancer - Non-Small Cell Lung Cancer - Endometrial Carcinoma - Ovarian Carcinoma
3 Locations available
- Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation
Conditions: Carcinoma, Non-small Cell Lung
5 Locations available
- Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02)
Conditions: Non-Small Cell Lung Cancer
1 Location available
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
13 Locations available
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
527 Locations available
- Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
161 Locations available
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer - Head and Neck Cancer - Breast Cancer - Non-small Cell Lung Cancer - Colorectal Cancer - Pancreatic Cancer - Ovarian Cancer - Esophageal Cancer - Gliomas
1 Location available
- Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer (Cetuximab Closed as of
Conditions: Lung Cancer
28 Locations available
- Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC
Conditions: Non-small Cell Lung Cancer
1 Location available
- A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Carcinoma (NSCLC)
Conditions: Non-Small Cell Lung Cancer
2 Locations available
- Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
1 Location available
- Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Conditions: Solid Tumor - Breast Cancer - Ovarian Cancer - Pancreatic Cancer - Non-Small Cell Lung
2 Locations available
- Pazopanib Hydrochloride With or Without Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Squamous Non-Small Cell Lung Cancer Pr
Conditions: Lung Cancer
1 Location available
- Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non-small Cell Lung Cancer
4 Locations available
- Hypofractionated Proton Radiation Therapy
Conditions: Non-small Cell Lung Cancer - Small Cell Lung Cancer - Carcinoid - Thymic Cancer - Lung Cancer
1 Location available
- Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung - Carcinoma, Small Cell Lung
1 Location available
- Carinal Biopsy Study
Conditions: Non-small Cell Lung Cancer
1 Location available
- SRS Study in Patients With Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer
1 Location available
- Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung
Conditions: Lung Cancer
1 Location available
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
143 Locations available
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
337 Locations available
- Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Conditions: Lung Cancer
1 Location available
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone
Conditions: Lung Cancer
1 Location available
- Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)
Conditions: Non-Small Cell Lung Cancer
1 Location available
- A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
5 Locations available
- Immunotoxin Therapy, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
297 Locations available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
363 Locations available
- Trial Of Cisplatin And KML-001 In Advanced Non-Small Cell Lung Cancer and Other Platinum Responsive Malignancies
Conditions: Advanced Non-Small Cell Lung Cancer - Platinum Responsive Malignancies
1 Location available
- Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platin
Conditions: Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
6 Locations available
- Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Conditions: Lung Cancer - Lung Cancer Non-Small Cell Cancer (NSCLC) - Lung Cancer Small Cell Lung Cancer (SCLC) - Mesothelioma
1 Location available
- Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer
Conditions: NSCLC (Advanced Non-small Cell Lung Cancer)
14 Locations available
- Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of th
Conditions: Non Small Cell Lung Cancer - NSCLC
18 Locations available
- AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Trial of Microdosing Carboplatin
Conditions: Carcinoma, Non-Small-Cell Lung - Urinary Bladder Neoplasms
1 Location available
- Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
3 Locations available
- Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura
Conditions: Lung Cancer - Metastatic Cancer
1 Location available
- Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
13 Locations available
- Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
1 Location available
- Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Conditions: Lung Cancer - Non Small Cell Lung Cancer
12 Locations available
- Imaging Markers in Targeting Radiation Therapy in Patients With Stage I, Stage II, Stage IIIA, or Stage IIIB Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
Conditions: Lung Cancer
5 Locations available
- Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
11 Locations available
- Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Conditions: Non-small Cell Lung Cancer
3 Locations available
- A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Sho
Conditions: Non-Small Cell Lung Cancer (NSCLC)
3 Locations available
- DNA Chip Based Prognosis of Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
2 Locations available
- A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non Small Cell Lung Cancer
20 Locations available
- Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
Conditions: Non-Small-Cell Lung Cancer
11 Locations available
- Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Locally Advanced Non-small Cell Lung Cancer
3 Locations available
- Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
4 Locations available
- A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung
Conditions: NSCLC - Solid Tumors
1 Location available
- A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreate
Conditions: Carcinoma, Non-Small-Cell Lung
51 Locations available
- Trial of Adjuvant Combined Epigenetic Therapy With 5-azacitidine and Entinostat in Resected Stage I Non-small Cell Lung Cancer Versus Standard Care
Conditions: Resected Stage I Non-Small Cell Lung Cancer
1 Location available
- Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
Conditions: Lung Cancer - Non Small Cell Lung Carcinoma - Hypermethylation
1 Location available
- Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer - Lung Cancer - NSCLC
1 Location available
- Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Ce
Conditions: Non Small Cell Lung Carcinoma
3 Locations available
- Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
Conditions: Non-small Cell Lung Cancer
2 Locations available
- Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer - Neoplasm Metastasis
1 Location available
- Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung - Carcinoma, Small Cell Lung - Carcinoma, Thymic
2 Locations available
- Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors
Conditions: Neuroendocrine Cancer - Small Cell Lung Cancer - Non-Small Cell Lung Cancer - Gastric Cancer
1 Location available
- Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
Conditions: Lung Cancer
1 Location available
- Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Conditions: Ovarian Cancer - Renal Cancer - Non-small Cell Lung Cancer - Small Cell Lung Cancer - Solid Tumors - Multiple Myeloma
7 Locations available
- A Phase I/II Trial of Stereotactic Body Radiation Therapy
Conditions: Inoperable Stage I/II Non-small Cell Lung Cancer
1 Location available
- Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer - Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
4 Locations available
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lun
Conditions: Lung Cancer
1 Location available
- PF-00299804 As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
Conditions: Carcinoma, Non-small Cell
6 Locations available
- Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Conditions: Non Small Cell Lung Cancer
2 Locations available
- A Study of Paclitaxel/Carboplatin With or Without IMC-3G3 in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Conditions: Non-Small Cell Lung Cancer
21 Locations available
- Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy
Conditions: Lung Cancer - Radiation Toxicity
1 Location available
- Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetax
Conditions: Non-small Cell Lung Cancer
4 Locations available
- Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance St
Conditions: Lung Cancer
2 Locations available
- Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Conditions: Non-squamous Non-small Cell Lung Cancer
1 Location available
- Understanding Mechanisms of Acquired Resistance to BIBW2992
Conditions: Non-small Cell Lung Cancer - EGFR Mutations
1 Location available
- A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy
Conditions: Non-small-cell Lung Cancer
5 Locations available
- Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
Conditions: Non-small Cell Lung Cancer
1 Location available
- A Phase II Study of the Selective BRAF Kinase Inhibitor GSK2118436 in Subjects With Advanced Non-small Cell Lung Cancer and BRAF Mutations
Conditions: Non-Small Cell Lung Cancer - Cancer
4 Locations available
- Evaluation of Cancer Care Coordination in the National Cancer Institutes' Community Cancer Center Programs
Conditions: Non-Small Cell Lung Cancer (Stage III) - Colon Cancer (Stage II & III) - Rectal Cancer (Stage III)
1 Location available
- Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
Conditions: Muscle Wasting - Non-Small Cell Lung Cancer
30 Locations available
- Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)
Conditions: Cachexia - Non-Small Cell Lung Cancer
13 Locations available
- Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Lung Cancer
3 Locations available
- Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
1 Location available
- Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
99 Locations available
- Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer - Non-Small Cell Lung Cancer
1 Location available
- Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis
Conditions: Lung Cancer - Metastatic Cancer
2 Locations available
- Image-Guided Adaptive Conformal Photon Versus Proton Therapy
Conditions: Non-Small-Cell Lung Carcinoma
2 Locations available
- Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer
Conditions: Non-Small Cell Lung Cancer - Small-Cell Lung Cancer
4 Locations available
- Study of Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Advanced Non-Small Cell Lung Cancer
5 Locations available
- A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevaciz
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
2 Locations available
- An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lym
Conditions: Neoplasms Malignant
13 Locations available
- Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked Cigarettes
Conditions: Lung Cancer
1 Location available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma - Liver Cancer - Adrenal Cancer
2 Locations available
- A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Adults With Previously Untreated, Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
23 Locations available
- Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475
Conditions: Cancer, Solid Tumor
13 Locations available
- STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO)
Conditions: Non-small Cell Lung Cancer (NSCLC)
1 Location available
- Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-S
Conditions: Stage IV Non-small Cell Lung Cancer
3 Locations available
- Histology-based Consolidation Chemotherapy Following Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)
Conditions: Stage III Non-small Cell Lung Cancer
1 Location available
- Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
22 Locations available
- Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects
Conditions: Non Small Cell Lung Cancer (NSCLC)
2 Locations available
- Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
Conditions: Solid Tumors - Non-Small Cell Lung Cancer (NSCLC)
1 Location available
- Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer Stage IIIB - Non-small Cell Lung Cancer Stage IV - Non-small Cell Lung Cancer Metastatic
7 Locations available
- Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Conditions: Breast Cancer - Lung Cancer - Carcinoma, Non-Small-Cell Lung - Cancer of Brain and Nervous System - Glioblastoma
1 Location available
- Early Palliative Care With Standard Oncology Care Versus Standard Oncology Care Alone in Advanced Lung and Non-colorectal Gastrointestinal Malignancie
Conditions: Non-small Cell Lung Cancer - Small Cell Lung Cancer - Mesothelioma - Esophageal Cancer - Gastric Cancer - Liver Cancer - Biliary Cancer
1 Location available
- Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Ut
Conditions: Non-small Cell Lung Cancer
1 Location available
- Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Conditions: Lung Cancer
3 Locations available
- Stage IIIB/IV Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
1 Location available
- Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel
Conditions: Non-small Cell Lung Cancer
7 Locations available
- Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma
4 Locations available
- A Study of DS-2248, in Subjects With Advanced Solid Tumors
Conditions: Solid Tumors - Non-small Cell Lung Carcinoma
2 Locations available
- Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Who Are Light or Never Sm
Conditions: Lung Cancer
2 Locations available
- Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With
Conditions: Adenocarcinoma of the Lung - Adenosquamous Cell Lung Cancer - Large Cell Lung Cancer - Recurrent Non-small Cell Lung Cancer - Squamous Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Ce
1 Location available
- A Study of Avastin (Bevacizumab) in Combination With Standard of Care Treatment in Patients With Lung Cancer
Conditions: Non-Small Cell Lung Cancer
3 Locations available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Conditions: Colorectal Cancer - Squamous Cell Head and Neck Cancer - Non-small Cell Lung Cancer - Triple Negative Breast Cancer - Other Tumors With EGFR Dependence
2 Locations available
- Multi-arm Study of BMS-936558 in Combination With 3 Platinum-based Doublet Chemotherapy Regimens in Subjects With Treatment-Naive Stage IIIB/IV Non-sm
Conditions: Non-small Cell Lung Cancer
7 Locations available
- A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
2 Locations available
- Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal - Mesothelioma - Ovarian Neoplasms - Carcinoma, Non-Small-Cell Lung
1 Location available
- Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonrespon
Conditions: Lung Cancer
5 Locations available
- A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Conditions: Advanced Malignancies - Carcinoma, Non-Small-Cell Lung - Anaplastic Large Cell Lymphoma - Diffuse Large Cell Lymphoma - Inflammatory Myofibroblastic Tumors
6 Locations available
- A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Conditions: Mesothelioma - Pancreatic Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
1 Location available
- Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
1 Location available
- Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Canc
Conditions: Non Small Cell Lung Cancer
1 Location available
- Study to Evaluate Safety, Pharmacokinetics, and Preliminary Efficacy of CO-1686 in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) N
Conditions: Locally Advanced or Metastatic Non-small Cell Lung Cancer.
2 Locations available
- A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With
Conditions: Non-Small -Cell Lung Cancer
1 Location available
- A Clinical Study Testing The Safety and Efficacy of CH5424802 in Patients With ALK Positive Non-Small Cell Lung Cancer
Conditions: ALK-Rearranged Non-Small Cell Lung Cancer
2 Locations available
- Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Conditions: Recurrent Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer - Stage IIIB Non-small Cell Lung Cancer
1 Location available
- Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Stage IIIA Non-small Cell Lung Cancer - Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
3 Locations available
- Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
2 Locations available
- -02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung - Adenocarcinoma - Carcinoma, Squamous Cell - Carcinoma, Large Cell
1 Location available
- Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum
Conditions: Carcinoma, Small Cell - Carcinoma, Non-small-cell Lung - Esophageal Neoplasms - Mesothelioma
1 Location available
- KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)
Conditions: Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
6 Locations available
- Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic - Small Cell Lung Carcinoma
5 Locations available
- Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
1 Location available
- Phase 1b Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer
1 Location available
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
167 Locations available
- Phase II Trial of Pulsed Paclitaxel With Concurrent Thoracic Radiotherapy, and Adjuvant Gemcitabine and Carboplatin in Stage IIIA and IIIB Non-Small C
Conditions: Non Small Cell Lung Cancer
1 Location available
- Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR
Conditions: Non-small Cell Lung Cancer
8 Locations available
- Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
2 Locations available
- Chemotherapy and Radiation in Treating Patients With Stage 3 Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
45 Locations available
- Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
Conditions: Lung Cancer
50 Locations available
- A Randomized Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous Non-Small Cell Lung Cancer
Conditions: Recurrent Non Small Cell Lung Cancer
1 Location available
- Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer (NSCLC)
1 Location available
- A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
2 Locations available
- Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507
Conditions: Lung Cancer
1 Location available
- Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
Conditions: Advanced Non-small Cell Lung Cancer - Postmenopausal Women
1 Location available
- A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
Conditions: Advanced Malignancies, Non-small Cell Lung Cancer
2 Locations available
- Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Conditions: Pancreatic Cancer - Liver Cancer - Lung Cancer - Lung Cancer Non-Small Cell Cancer (NSCLC) - Lung Cancer Small Cell Lung Cancer (SCLC) - Hepatobiliary Cancers - Hepatobiliary Cancers Liver - Hepatobiliary Cancers Hepatocellular Carcinoma (Hepatoma) - Hepa
1 Location available
- Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
Conditions: Stage IIIA Non-small Cell Lung Cancer
1 Location available
- RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Patients With Non-Small Cell Lung Cancer and Platinum Resistant Ovarian Cancer
Conditions: Non-Small Cell Lung Cancer, Ovarian Cancer
3 Locations available
- Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurre
Conditions: Non-Small Cell Lung Cancer
6 Locations available
- Standard Chemotherapy With Blueberry Powder in Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
1 Location available
- Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer (NSCLC) - Stage IV NSCLC - Metastatic NSCLC
1 Location available
- Study Evaluating the Safety and Efficacy Of Carboplatin/Paclitaxel And Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With P
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Conditions: Bladder Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter
5 Locations available
- MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erloti
Conditions: Lung Cancer
7 Locations available
- Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
11 Locations available
- Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involv
Conditions: Lung Cancer
1 Location available
- Seamless Study Of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable
Conditions: Lung Cancer
1 Location available
- Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)
Conditions: Muscle Wasting - Non Small Cell Lung Cancer
27 Locations available
- ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer (NSCLC)
55 Locations available
- Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 1)
Conditions: Cachexia - Non-Small Cell Lung Cancer
7 Locations available
- Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)
Conditions: Cachexia - Non-Small Cell Lung Cancer
14 Locations available
- A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects W
Conditions: Non-Small Cell Lung Cancer (NSCLC)
13 Locations available
- A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Patients With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have R
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
Conditions: Lung Cancer - Non Small Cell Lung Cancer (NSCLC) - Breast Cancer - ER+ Breast Cancer
2 Locations available
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung - Non-Small Cell Lung Cancer
1 Location available
- Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Conditions: Lung Cancer
119 Locations available
- Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
5 Locations available
- Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease
Conditions: Lung Cancer
1 Location available
- Erlotinib With or Without IMC-A12 in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
2 Locations available
- Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
12 Locations available
- Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (
Conditions: Non-Small Cell Lung Cancer
4 Locations available
- Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
Conditions: Non-small Cell Lung Cancer
4 Locations available
- A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer
Conditions: Carcinoma, Non-small-cell Lung
2 Locations available
- Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precan
Conditions: Cancer Survivor - Esophageal Cancer - Head and Neck Cancer - Lung Cancer - Precancerous Condition
1 Location available
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
23 Locations available
- Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer - Gastric Cancer - Bladder Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
2 Locations available
- RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy
Conditions: Lung Cancer
1 Location available
- Ridaforolimus With Cetuximab for Patients With Advanced Head and Neck Cancer, Non-Small Cell Lung Cancer and Colon Cancer
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Selumetinib and Erlotinib Hydrochloride in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Lung Cancer
2 Locations available
- Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung - Non-small Cell Lung Cancer
1 Location available
- Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small
Conditions: Anemia - Carcinoma, Non-Small-Cell Lung - Carcinoma, Small-Cell Lung - Bladder Cancer - Cancer of Head and Neck - Uterine Cervical Cancer
39 Locations available
- Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation
Conditions: Stage IIIA Non-small Cell Lung Cancer
1 Location available
- First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
Conditions: Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion - Stage IV Non-small Cell Lung Cancer
3 Locations available
- Pioglitazone Hydrochloride in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Erlotinib Plus ARQ 197 Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Conditions: Metastatic Non-Small Cell Lung Cancer
8 Locations available
- Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer
1 Location available
- Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
Conditions: Non-Small Cell Lung Cancer
4 Locations available
- Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer
1 Location available
- Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer
Conditions: Unresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)
5 Locations available
- CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
14 Locations available
- The Effect of Beta-glucan in Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer
1 Location available
- Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
Conditions: Melanoma - Non-Small Cell Lung Cancer - Lung Cancer, Non-Small Cell
1 Location available
- A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
4 Locations available
- Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
163 Locations available
- Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer
Conditions: Brain Cancer - Neoplasm Metastasis - Lung Cancer - Lung Cancer Non-Small Cell Cancer (NSCLC)
1 Location available
- Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer
Conditions: Carcinoma, Non Small Cell Lung
1 Location available
- A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors
Conditions: Non-Small Cell Lung Cancer, Solid Cancers
2 Locations available
- Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
Conditions: Advanced Non-squamous Non-Small Cell Lung Cancer
1 Location available
- Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC
Conditions: Non-Small Cell Lung Cancer
1 Location available
- A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Patients Who Received Prior First Line Platin
Conditions: Non Small Cell Lung Cancer
100 Locations available
- A Phase I Study of MGAH22 in Patients With Refractory HER2 Positive Cancers
Conditions: Non-Small Cell Lung Neoplasms - Prostate Neoplasms - Bladder Neoplasms - Ovarian Neoplasms - Breast Neoplasms
1 Location available
- A Study in Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma
3 Locations available
- An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Conditions: Carcinoma, Non-Small-Cell Lung - Head and Neck Neoplasms
4 Locations available
- A Study of First-line Maintenance Tarceva (Erlotinib) Versus Tarceva at Time of Disease Progression in Patients With Advanced Non-small Cell Lung Canc
Conditions: Non-Small Cell Lung Cancer
1 Location available
- An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer
Conditions: Lung Cancer, Non-Small Cell
15 Locations available
- Molecular Analysis of Thoracic Malignancies
Conditions: Thymus Cancer - Thymoma - Thymic Carcinoma - Lung Cancer - Carcinoma, Non-Small-Cell Lung - Mesothelioma
1 Location available
- Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed
Conditions: Lung Cancer
21 Locations available
- Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
1 Location available
|